Cite
HARVARD Citation
Kazankov, K. et al. (2016). Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma. Scandinavian journal of clinical & laboratory investigation. pp. 64-73. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kazankov, K. et al. (2016). Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma. Scandinavian journal of clinical & laboratory investigation. pp. 64-73. [Online].